Although these studies provided evidence to separate EBV+ NT/NKCL from ENKTL and PTCL-NOS, the JAK/STAT signal pathway mutation profile overlaps with that of ALK-negative ALCL [20]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.